INDUSTRY

Medical Devices Industry Stocks

The Medical Devices industry covers 141 US-listed companies on StockSifting — NYSE and NASDAQ stocks operating within the Healthcare sector of the American equity market. Companies in the Medical Devices space compete on recurring themes including Healthcare, System, Surgical, Headquartered, Well, which drive revenue growth, margin expansion, and long-term capital allocation decisions across the group. Representative names such as Abbott Laboratories, Stryker Corporation, Medtronic plc, and Boston Scientific Corporation show how businesses in this industry pursue differentiated strategies — through proprietary technology, distribution scale, pricing power, brand strength, or regulatory moats — to sustain returns above the cost of capital. For US investors, an industry-level screener is one of the most efficient ways to compare true peers: companies that face the same end-market demand, regulatory framework, raw material costs, and macroeconomic sensitivities, making valuation comparisons far more meaningful than cross-sector analysis. Key metrics to compare across Medical Devices industry stocks include P/E ratio for earnings valuation, ROCE for capital efficiency, ROE for equity profitability, Dividend Yield for income generation, Market Capitalisation for size and liquidity context, and the 52-week trading range for price momentum signals. Use the sortable table below to rank all 141 Medical Devices companies by any fundamental metric and identify which US-listed stocks in this industry offer the most attractive combination of quality, value, and income for your investment portfolio.

How to Analyse Medical Devices Industry Stocks

The Medical Devices industry page on StockSifting is built for US investors who want true peer comparison — businesses facing the same end-market dynamics, regulatory environment, and competitive pressures. Start by sorting the table by ROCE to identify the most capital-efficient operators in the group, then cross-reference with P/E to find high-quality companies available at reasonable valuations. Check Dividend Yield for income-oriented screening and the 52-week High/Low range for price momentum context. Click any company name to open its full profile — including quarterly financials, analyst data, and key ratios — to complete your due diligence before making any investment decision. All data is sourced from NYSE and NASDAQ filings and refreshed daily after US market close.

Key Metrics Explained for Medical Devices Industry Stocks

Every metric in the table below has a specific analytical purpose when comparing Medical Devices industry companies. Understanding what each ratio measures — and what a strong or weak reading looks like within this industry — is essential for making informed investment decisions.

P/E Ratio (Price-to-Earnings)
Measures how much investors pay for each dollar of trailing twelve-month earnings. A lower P/E relative to Medical Devices industry peers suggests a cheaper valuation; a higher P/E may reflect premium growth expectations or temporary earnings compression. Always compare P/E within the same industry — cross-sector P/E comparisons are misleading because capital intensity, growth rates, and margin profiles differ structurally.
Market Capitalisation
Total market value of a company's outstanding shares (price × shares outstanding). Within the Medical Devices industry, market cap indicates size, liquidity, and index eligibility. Large-cap companies (above $10B) typically offer more analyst coverage and tighter bid-ask spreads; small-caps may offer higher growth potential with commensurately higher risk and lower trading liquidity.
ROCE — Return on Capital Employed
Operating profit divided by total capital employed (equity + debt). ROCE is one of the most revealing profitability metrics for Medical Devices industry comparison: it shows which companies generate the most operating profit per dollar of total capital invested. ROCE consistently above 15% signals a strong competitive position; above 25% signals an exceptional business with durable advantages. Companies with high ROCE can self-fund growth and generate superior long-term shareholder returns without requiring continuous equity dilution or heavy borrowing.
ROE — Return on Equity
Net income divided by shareholders' equity. ROE measures how efficiently management generates profit from the equity shareholders have invested. In the Medical Devices industry, ROE above 15% is generally considered strong; below 8% raises questions about capital allocation efficiency. Note: high ROE driven by excessive leverage (high D/E ratio) is a warning sign rather than a quality indicator — always check debt levels alongside ROE.
Dividend Yield
Annual dividends per share as a percentage of the current share price. For income-oriented US investors, dividend yield is a key criterion — particularly in Medical Devices industry companies with stable, recurring cash flows. A yield significantly above the industry median may indicate an attractive income opportunity or, alternatively, a price decline that warrants further investigation into dividend sustainability. Always verify payout ratio and free cash flow coverage before relying on a high yield as an investment signal.
52-Week High / 52-Week Low
The highest and lowest traded prices over the past 52 weeks. The 52-week range provides immediate context on price momentum and volatility within the Medical Devices industry: stocks trading near their 52-week high may reflect strong business momentum or elevated valuation; stocks near their 52-week low may represent contrarian opportunities or reflect deteriorating fundamentals. Always cross-reference with fundamental metrics rather than relying on price range alone.

Data Sources & Methodology

All financial data displayed on this Medical Devices industry page is sourced from NYSE and NASDAQ company filings, processed through StockSifting's daily data pipeline, and refreshed after each US market close. Fundamental metrics — earnings per share, book value, debt, and revenue — are updated as companies file quarterly reports (10-Q) and annual reports (10-K) with the SEC. Price data reflects the most recent closing price. StockSifting does not provide financial advice. All screening tools are for research and informational purposes only. Conduct your own due diligence before making any investment decision.

Medical Devices Industry Stocks — Frequently Asked Questions

Common questions US investors ask about the Medical Devices industry, answered with data from StockSifting's live screener.

What industry is Medical Devices on the US stock market?

Medical Devices is a recognised industry classification on the US equity market. StockSifting currently tracks 141 NYSE- and NASDAQ-listed companies in the Medical Devices industry, ranging from large-cap S&P 500 constituents to smaller-cap names. The Medical Devices industry page consolidates all these companies into a single sortable view, with live P/E ratio, market cap, ROCE, ROE, dividend yield, and 52-week price range data refreshed daily after US market close.

How many US stocks are in the Medical Devices industry?

StockSifting tracks 141 US-listed companies in the Medical Devices industry across NYSE and NASDAQ. Use the sortable table above to compare them by valuation, profitability, dividend yield, and trading range. Click any company name to open its full profile page with quarterly financials, key ratios, and historical data.

What metrics matter most for Medical Devices industry analysis?

For the Medical Devices industry, the most informative metrics to compare across peers are:

  • ROCE — identifies companies with durable competitive advantages generating high returns on invested capital.
  • P/E Ratio — measures relative valuation; low P/E within the industry may signal undervaluation.
  • ROE — reveals how efficiently management deploys shareholder equity to generate profit.
  • Dividend Yield — key for income-oriented US investors screening for reliable cash distributions.
  • Market Cap — size and liquidity context; large-caps offer stability, small-caps offer growth potential.
  • 52-Week Range — price momentum and volatility signal at a glance.

Comparing these metrics within the Medical Devices industry is more meaningful than cross-sector comparisons, because all companies face similar structural dynamics, cost bases, and regulatory environments.

How do I find the best Medical Devices industry stocks?

There is no single definition of "best" — it depends on your investment objective:

  • Quality investors: Sort by ROCE descending to identify the most capital-efficient operators. Look for ROCE above 15% sustained over multiple years, combined with low D/E.
  • Value investors: Sort by P/E ascending to find the cheapest earnings. Cross-reference with ROCE to avoid cheap junk — look for low P/E AND high ROCE simultaneously.
  • Income investors: Sort by Dividend Yield descending. Verify sustainability by checking payout ratio and free cash flow in individual company profiles.
  • Growth investors: Filter by market cap for smaller-cap names with high ROE, indicating efficient growth reinvestment.

Always click through to individual company pages for full due diligence. Nothing on this page constitutes financial advice. Past performance does not guarantee future results.

How often is the Medical Devices industry data updated?

StockSifting refreshes all Medical Devices industry data — price, P/E, market cap, ROCE, ROE, dividend yield, and 52-week range — daily after US market close. Fundamental data (earnings, book value, debt ratios) updates as companies file quarterly 10-Q and annual 10-K reports with the SEC. This means the screener reflects the most current publicly available information for every NYSE- and NASDAQ-listed company in the Medical Devices industry.

141 Companies in the Medical Devices Industry

Compare US-listed Medical Devices industry stocks by price, P/E ratio, market cap, dividend yield, ROCE, ROE, and 52-week high-low range. Click any column header to sort. Click any company name for the full profile.

Click any column header to sort.
# Company Price P/E Mkt Cap Div Yield ROCE ROE 52W High 52W Low
1 Abbott Laboratories $99.67 32.43 $175.92 B 2.53% 11.47% 12.2% $137.49 $81.97
2 Stryker Corporation $314.58 36.25 $120.97 B 1.12% 12.63% 15.1% $404.87 $281
3 Medtronic plc $82.35 21.77 $104.52 B 0.03% 8.3% 9.85% $106.33 $73.31
4 Boston Scientific Corporation $43.19 18.11 $64.55 B 0% 10.39% 14.87% $109.5 $42.2
5 Edwards Lifesciences Corporation $84.55 43.98 $48.21 B 13.77% 10.59% $96.29 $72.3
6 DexCom, Inc. $74.75 30.82 $28.68 B 21.72% 33.83% $89.98 $54.11
7 GE HealthCare Technologies Inc. $62.04 14.78 $28.23 B 0.22% 9.93% 18.75% $89.77 $58.75
8 Koninklijke Philips N.V. $26.58 23.76 $26.22 B 0.01% 7.46% 8.95% $27.7 $21.44
9 STERIS plc $211.75 26.39 $20.65 B 0.01% 10.53% 11.06% $269.44 $195.14
10 Zimmer Biomet Holdings, Inc. $88.92 23.17 $17.63 B 1.04% 6.61% 6.01% $108.29 $79.12
11 Smith & Nephew plc $30.21 20.81 $12.97 B 0.01% 9.67% 11.55% $1,441.5 $1,062.5
12 Penumbra, Inc. $317.39 73.03 $12.49 B 11.52% 12.32% $362.41 $221.26
13 Insulet Corporation $163.72 37.41 $11.33 B 18.87% 17.37% $354.88 $138.79
14 Globus Medical, Inc. $76.09 17.58 $10.31 B 11.18% 13.04% $101.4 $51.79
15 Masimo Corporation $179.95 123.5 $9.42 B 23.57% 9.08% $179.99 $125.94
16 Bruker Corporation $60.43 $9.09 B 0.34% 4.76% -0.51% $64.54 $28.53
17 Glaukos Corporation $153.09 $9 B -25.2% -26.46% $161.53 $73.16
18 Bio-Rad Laboratories, Inc. $301.7 47.67 $8.05 B 2.17% 2.4% $343.12 $236.73
19 Bio-Rad Laboratories, Inc. $309.37 47.67 $8.05 B 2.17% 2.4% $343.12 $236.73
20 Bio-Rad Laboratories, Inc. $267.43 44.42 $7.16 B 0.02% $321.12 $244.54
21 LivaNova PLC $79.84 40.87 $5.86 B 11.09% 9.14% $85.27 $41.02
22 iRhythm Holdings, Inc. $109 $3.59 B -5.75% -20.6% $212 $100.85
23 Haemonetics Corporation $78.07 36.23 $3.53 B 10.74% 11.32% $87.32 $47.32
24 Integer Holdings Corporation $96.31 22.93 $3.25 B 7.52% 8.23% $116.31 $62
25 Establishment Labs Holdings Inc. $95.65 $2.82 B -14.18% -225.86% $96.99 $33.35
26 TransMedics Group, Inc. $74.29 14.97 $2.57 B 11.09% 41.92% $156 $60.1
27 Neogen Corporation $9.93 $2.17 B -0.05% -29% $11.43 $4.56
28 Axogen, Inc. $40.26 $2.1 B -3.96% -20.74% $46.95 $11.27
29 UFP Technologies, Inc. $243.94 27.68 $1.9 B 16.02% 16.61% $279.49 $173.86
30 NovoCure Limited $16 $1.88 B -26.47% -39.38% $18.92 $9.82
31 Butterfly Network, Inc. $6.82 $1.75 B -37.34% -36.84% $9.69 $1.32
32 Enovis Corporation $27.1 $1.53 B -0.58% -60.13% $34.28 $19.14
33 Alamar Biosciences, Inc. $21.96 $1.52 B $27.2 $18.85
34 AdaptHealth Corp. $11.21 $1.51 B 5.17% -5.11% $13.43 $8.51
35 Inspire Medical Systems, Inc. $52.49 11.46 $1.5 B 6.28% 17.98% $147.03 $38.91
36 Integra LifeSciences Holdings Corporation $19.01 $1.46 B 0.57% -47.65% $20.26 $8.7
37 CONMED Corporation $41.88 23.02 $1.26 B 1.85% 5.1% 5.4% $56.64 $31.44
38 Alphatec Holdings, Inc. $8.3 $1.25 B -10.13% -366.63% $23.29 $6.82
39 Tandem Diabetes Care, Inc. $17.6 $1.24 B -26.21% -68.29% $29.65 $9.98
40 IRADIMED CORPORATION $94.97 52.53 $1.24 B 0.82% 26.52% 24.48% $107.9 $55.11
41 Artivion, Inc. $24.94 104.79 $1.22 B 3.41% 2.66% $48.25 $19.16
42 Avanos Medical, Inc. $24.98 $1.17 B 1.7% -9.55% $25.49 $9.3
43 QuidelOrtho Corporation $16.43 $1.1 B 1.14% -56.31% $35.58 $9.92
44 Lumexa Imaging Holdings, Inc. $11.13 $1.07 B 1.69% -8.04% $19.45 $6.45
45 PROCEPT BioRobotics Corporation $18.52 $1.06 B -23.48% -27.7% $60.57 $17.96
46 Bioventus Inc. $11.88 34.58 $984.88 M 10.76% 16.27% $12.53 $5.81
47 InMode Ltd. $15.36 10.11 $881.47 M 12.27% 13.28% $16.74 $12.72
48 Beta Bionics, Inc. $17.62 $794.09 M -24.07% -23% $32.71 $8.8
49 SI-BONE, Inc. $17.04 $755.71 M -10.47% -9.55% $21.89 $11.48
50 SS Innovations International, Inc. $3.58 $720.47 M -17.08% -23% $10 $3.11
51 CeriBell, Inc. $17.89 $683.73 M -33.07% -38.19% $24.33 $10.85
52 Tactile Systems Technology, Inc. $28.43 31.69 $643.3 M 12.57% 9.7% $37.77 $9.41
53 Cerus Corporation $3.12 $629.16 M -7.17% -15.36% $3.47 $1.15
54 Cytek Biosciences, Inc. $4.57 $583.72 M -10.52% -20.77% $6.18 $3.09
55 NeuroPace, Inc. $15.46 $523 M -18.62% -120.74% $19.6 $7.56
56 OrthoPediatrics Corp. $19.49 $500.47 M -6.27% -11.42% $23.7 $14.42
57 Mobia Medical, Inc. $14.25 $473.8 M -2.46% $15.29 $10.19
58 Orthofix Medical Inc. $11.63 $469.3 M -12.14% -13.44% $16.99 $8.85
59 ClearPoint Neuro, Inc. $15.41 $462.44 M -27.78% -140.96% $30.1 $8.27
60 Viemed Healthcare, Inc. $11.92 30.87 $459.66 M 13.1% 10.66% $12.61 $5.93
61 Varex Imaging Corporation $10.72 $450.89 M 7.18% -17.61% $14.56 $6.76
62 Delcath Systems, Inc. $12.81 783.35 $439.46 M 0.59% 0.51% $13.74 $8.12
63 Pacific Biosciences of California, Inc. $1.4 $422.42 M -78.39% -488.45% $2.73 $1.09
64 CapsoVision, Inc. $7.02 $353.49 M -185.75% -184.24% $15.37 $3.43
65 Profound Medical Corp. $6.91 $348.84 M -57.78% -78.88% $12.4 $5.23
66 Electromed, Inc. $40.52 33.5 $338.49 M 22.29% 22.14% $47.4 $17.73
67 Perspective Therapeutics, Inc. $2.98 $337.01 M -47.66% -41.84% $6.16 $1.96
68 Standard BioTools Inc. $0.88 4.25 $332.74 M -20.31% 17.29% $1.72 $0.7
69 908 Devices Inc. $7.35 14.16 $298.06 M -16.46% -25.63% $9.34 $5.03
70 Treace Medical Concepts, Inc. $4.23 $273.12 M -33.86% -69.5% $7.78 $1.17
71 Sight Sciences, Inc. $4.91 $268.51 M -35.58% -59.1% $9.24 $3.11
72 Senseonics Holdings, Inc. $5.03 $265.71 M -67.05% -130% $12.52 $4.79
73 TriSalus Life Sciences, Inc. $4.34 $264.71 M -113.07% 12.02% $7.95 $2.2
74 RxSight, Inc. $5.25 $216.71 M -16.88% -17.01% $13.22 $4.48
75 Lucid Diagnostics Inc. $0.97 $196.2 M -418.44% -370.21% $1.63 $0.9
76 Quanterix Corporation $3.97 $186.07 M -31.92% -35.17% $8.77 $2.4
77 Quantum-Si incorporated $0.84 $182.72 M -43.74% -47.35% $3.1 $0.69
78 InfuSystem Holdings, Inc. $9.15 22.81 $180.42 M 14.83% 14% $11.04 $5.42
79 Apyx Medical Corporation $4.12 $176.87 M -11.69% -90.62% $5.08 $1.59
80 Inogen, Inc. $6.43 $173.28 M -12.85% -12.9% $9.13 $5.34
81 Owlet, Inc. $5.53 $159.56 M -19.96% -35.14% $16.94 $4.19
82 AVITA Medical, Inc. $5.09 $158.19 M 676.75% -337.9% $7.12 $3.22
83 CVRx, Inc. $4.97 $132.02 M -56.04% -120.77% $11.3 $4.37
84 MaxCyte, Inc. $1.23 $130.69 M -24.06% -22.03% $2.37 $0.64
85 Neuronetics, Inc. $1.88 $129.78 M -28.31% -164.68% $4.85 $0.8
86 Rapid Micro Biosystems, Inc. $2.1 $105 M -84.08% -131.52% $4.94 $1.66
87 Hyperfine, Inc. $0.99 $97.14 M -85.19% -101.28% $2.22 $0.85
88 Sera Prognostics, Inc. $2.27 $88.11 M -46.95% -41.02% $3.95 $1.56
89 Nano-X Imaging Ltd. $1.08 $77.95 M -28.95% -51.88% $5.69 $0.73
90 Outset Medical, Inc. $4.12 $75.92 M -29.4% -55.88% $19.6 $3
91 LENSAR, Inc. $5.76 2.37 $69.57 M -79.65% 147.85% $13.43 $5.06
92 Xtant Medical Holdings, Inc. $0.44 34.57 $63.12 M 11.26% 3.68% $0.95 $0.39
93 Spectral AI, Inc. $1.68 $53.94 M -1104.36% -730.01% $2.97 $1.18
94 Pulmonx Corporation $1.27 $53.85 M -49.13% -92.94% $3.88 $1.13
95 SANUWAVE Health, Inc. $6.07 3.28 $52.58 M 25.36% 270.18% $46.59 $6
96 Envoy Medical, Inc. $0.68 $52.39 M 3.48% 741.34% -42.82% $1.89 $0.36
97 electroCore, Inc. $6.4 $52.01 M -179.71% -235.81% $10.49 $4.16
98 Sensus Healthcare, Inc. $3.04 $50.21 M -21.33% -15.79% $5.92 $2.66
99 Elutia Inc. $0.95 0.84 $42 M -49.48% 252.28% $2.5 $0.5
100 QT Imaging Holdings, Inc. $3.09 $41.86 M -29.28% -93.6% $19.05 $3.25
101 PAVmed Inc. $5.54 86.59 $40.45 M -89.22% -49.65% $28.44 $3.85
102 Nortech Systems Incorporated $13.9 39.15 $40.32 M 2.95% 3.03% $18.01 $6.5
103 Myomo, Inc. $0.94 $37.66 M -47.54% -114.87% $2.22 $0.6
104 InspireMD, Inc. $0.71 $33.26 M -1.43% $2.93 $0.69
105 TELA Bio, Inc. $0.72 $32.24 M -53.21% -441.55% $2.19 $0.5
106 Accuray Incorporated $0.25 $30.32 M 2.82% -77.48% $2.1 $0.24
107 Cytosorbents Corporation $0.39 $23.89 M -41.3% -165.13% $1.22 $0.35
108 Pulsenmore Ltd. $3.56 $23.67 M -33.09% -20.12% $1,081.64 $314.95
109 Lifeward Ltd. $7.25 $20.6 M -155.52% -243.14% $10.56 $4.14
110 IRIDEX Corporation $1.13 $19.67 M -0.57% $1.65 $0.87
111 NeuroOne Medical Technologies Corporation $2.05 $17.8 M -49.83% -98.33% $6.96 $2.09
112 VolitionRx Limited $1.43 $16.57 M $18.8 $1.3
113 Inspira Technologies Oxy B.H.N. Ltd. $1.18 $16.44 M -541.24% -1089.59% $3.85 $0.28
114 20/20 Biolabs, Inc. $0.55 $16.24 M -253.94% -5.03% $50 $0.49
115 Modular Medical, Inc. $2.79 $14.91 M -109.03% -286.34% $30 $2.6
116 Picard Medical, Inc. $0.12 $12.91 M -344.07% -712.64% $13.68 $0.11
117 Co-Diagnostics, Inc. $2.36 $12.62 M -147.54% -164.92% $46.5 $1.26
118 Nexalin Technology, Inc. $0.48 $10.81 M -223.88% -191.88% $2 $0.3
119 Adagio Medical Holdings, Inc. $0.44 $10.66 M -62.51% -159.53% $2.58 $0.49
120 Sintx Technologies, Inc. $1.58 $9.98 M -185.71% -366.49% $6.78 $1.52
121 IceCure Medical Ltd $3.36 $9.21 M -166.53% -211.73% $42 $2.12
122 HeartSciences Inc. $2.46 $7.96 M -1607.2% -333.38% $4.3 $1.63
123 enVVeno Medical Corporation $10.15 $6.74 M -76.16% -66.39% $196.7 $8.67
124 Baird Medical Investment Holdings Limited $1.09 62.91 $6.59 M 35.34% -115.22% $3.75 $0.76
125 Vivos Therapeutics, Inc. $0.41 $5.72 M -108.39% -351.28% $5.95 $0.38
126 Biomerica, Inc. $1.64 $5.15 M -122.16% -98.14% $4.6 $1.6
127 Phaos Technology Holdings (Caym $0.23 $4.96 M 214.51% -10.73% $7.39 $0.2
128 Intelligent Bio Solutions Inc. $1.81 $4.25 M -359.62% -174.17% $24.9 $1.58
129 Tivic Health Systems Inc $0.31 $4.03 M -25.51% -202.2% $5.6 $0.35
130 Beyond Air, Inc. $5.9 $3.97 M -177.71% -360.45% $95.6 $5.3
131 Tenon Medical, Inc. $0.2 $3.53 M -169.5% -269.24% $2.48 $0.19
132 ENvue Medical, Inc. $0.36 $3.11 M -394.93% -49.46% $17.4 $0.35
133 Autonomix Medical, Inc. $4.29 $2.3 M -143.08% -239.36% $55.44 $4.19
134 INVO Fertility, Inc. $1.04 $1.88 M -26.69% -149.16% $169.6 $1
135 Catheter Precision, Inc. $0.49 $1.78 M -43.77% -196.29% $4.94 $0.31
136 Aethlon Medical, Inc. $0.61 $1.63 M -171.08% -137.73% $27.4 $0.6
137 Bluejay Diagnostics, Inc. $1.16 $1.17 M -115.88% -144.27% $16.68 $1.03
138 Nuwellis, Inc. $2.85 $1.04 M -359.88% -211.49% $555.45 $2.73
139 Profusa, Inc. $2 $1.01 M 8.32% -22.12% $4,162.5 $1.69
140 WORK Medical Technology Group LTD $1.87 $0.71 M -4.23% -6.84% $137,168.14 $1.78
141 iTonic Holdings Ltd. $0.28 $0.7 M -59.82% -93.93% $4.72 $0.25